Buscar
Congreso SOLACI
Home Tags Inflamation

Tag: inflamation

ESC 2021 | COVERT-MI: Colchicine Attempts to Reduce Infarct Size

solaci - 0
Colchicina post infarto: buenos resultados y costo-efectivo

Reducing Chronic Inflammation in Atherosclerosis with an Old Drug

solaci - 0
Dieta proinflamatoria y su potencial para desencadenar eventos cardiovasculares

Pro-Inflammatory Diet and Its Potential to Trigger Cardiovascular Events

solaci - 0
TAVI bajo riesgo

TAVR as Anti-Inflammatory? An effect few imagined

solaci - 0
Inflamación crónica, enfermedad coronaria y cáncer: distintas caras de una misma moneda

Chronic Inflammation, Coronary Artery Disease and Cancer: Same Coin, Different Sides

solaci - 0
AHA 2018 | PIONEER-HF: sacubitril/valsartan en insuficiencia cardíaca aguda descompensada

AHA 2018 | PIONEER-HF: Sacubitril/Valsartan in Acute Decompensated Heart Failure

solaci - 0
AHA 2018 | El metotrexate como anti inflamatorio no logró mostrar beneficios

AHA 2018 | No Benefits with Methothrexate as Anti-Inflammatory Drug

solaci - 0

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad